Tokyo, Jan. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060468) titled 'A Study on the Characteristics and Support for Patients Complaining of Cognitive Impairment' on Jan. 26.
Study Type:
Observational
Primary Sponsor:
Institute - The Jikei University School of Medicine
Condition:
Condition - Patients who visited the outpatient clinic with cognitive decline as their primary complaint
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to identify subtypes based on the results of neuropsychological tests used in clinical practice among elderly patients presenting with cognitive decline as their primary complaint, and to clarify the characteristics of these subtypes.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Individuals with a Montreal Cognitive Assessment score of 18 or higher
First-time patients
Key exclusion criteria - Individuals with other clearly defined neurological disorders that cause cognitive impairment
Individuals with mental disorders that affect their ability to understand test instructions or perform tasks
Target Size - 500
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2016 Year 04 Month 01 Day
Date of IRB - 2016 Year 04 Month 01 Day
Anticipated trial start date - 2016 Year 04 Month 01 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069181
Disclaimer: Curated by HT Syndication.
